Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Expectations for alendronate in orthopedic surgery].

H Katagiri1, H Hagino, T Okano

  • 1Department of Orthopedic Surgery, Faculty of Medicine, Tottori University.

Clinical Calcium
|March 19, 2005
PubMed
Summary

Alendronate is a promising osteoporosis treatment that also offers anti-inflammatory benefits. Its potential extends to preventing fractures and treating osteolysis, suggesting broader orthopedic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proximal Femoral Morphology in Development Dysplasia of the Hip Based on Three-Dimensional (3D) Analysis.

Malaysian orthopaedic journal·2025
Same author

Inferior Healing Rate in Isolated Meniscal Repair than that in Meniscal Repair with Concomitant ACL Reconstruction Evaluated with MRI.

Malaysian orthopaedic journal·2023
Same author

Effect of coordinator-based osteoporosis intervention on quality of life in patients with fragility fractures: a prospective randomized trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
Same author

Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021

Area of Science:

  • Orthopedics
  • Pharmacology
  • Inflammation Research

Context:

  • Osteoporosis management
  • Post-arthroplasty complications
  • Stress shielding in bone

Purpose:

  • Evaluate alendronate's anti-inflammatory properties
  • Explore alendronate's efficacy in fracture prevention
  • Assess alendronate's role in osteolysis treatment

Summary:

  • Alendronate demonstrates potential beyond osteoporosis treatment, exhibiting anti-inflammatory effects.
  • The drug is being considered for stress shielding and managing osteolysis following arthroplasty.
  • These findings suggest alendronate's utility in a wider range of orthopedic conditions.

Impact:

  • Broadens the therapeutic scope of alendronate.
  • Offers new treatment avenues for orthopedic disorders.
  • Highlights alendronate's multifaceted pharmacological action.

Related Experiment Videos